Market Analysis - The A-share market experienced a significant rebound, with the easing of geopolitical tensions related to the US-Iran conflict contributing to improved market sentiment. The Shanghai Composite Index rose by 0.65% to close at 4123.14 points, while the Shenzhen Component Index increased by 2.04% to 14354.07 points, and the ChiNext Index surged by 3.04% to 3306.14 points [2][5] - The technology growth sector led the market rally, with notable gains in communication equipment, electronics, and machinery sectors, which rose by 4.32%, 3.34%, and 2.72% respectively. Specific stocks in the computing hardware segment saw substantial increases, with gains of 8.03%, 7.52%, and 6.79% [5][7] - Despite the overall market rebound, trading volume decreased by 9.5% from the previous day, indicating a cautious approach among investors. The total market turnover was 2.42 trillion yuan [2][7] Bond Market - The bond futures market showed a mixed performance, with the 30-year main contract slightly rising by 0.04% to 111.490 yuan, while the 10-year contract remained stable at 108.305 yuan. The market is expected to maintain a volatile pattern, influenced by upcoming domestic economic data and central bank policy signals [8][14] - The central bank's net injection of 5.2 billion yuan reflects a proactive stance in maintaining adequate liquidity, with the overnight Shibor rate decreasing slightly, indicating sufficient interbank liquidity [8][14] Commodity Market - The commodity index fell by 2.10%, led by declines in energy and chemical sectors, with significant drops in crude oil and methanol prices. The market exhibited a pattern of profit-taking following previous geopolitical-driven gains [8][10] - Oil prices experienced high volatility, with Brent crude dropping from nearly 120 USD per barrel to around 90 USD, influenced by statements from US President Trump regarding the potential end of the conflict with Iran [8][10] Investment Opportunities - The report highlights several sectors with potential investment opportunities, including AI applications, commercial aerospace, nuclear fusion, quantum technology, brain-computer interfaces, robotics, and consumer goods, driven by policy support and technological advancements [11][12] - The precious metals sector is expected to benefit from central bank purchases and anticipated interest rate cuts by the Federal Reserve, while the non-ferrous metals sector may be influenced by supply constraints and fluctuations in the US dollar index [11][12]

Investment Rating - The investment rating for the company is "Buy" (maintained) [2][18] Core Insights - The company reported a revenue of 3.387 billion yuan in 2025, representing a year-on-year growth of 13.56%, and a net profit attributable to shareholders of 371.61 million yuan, with a year-on-year increase of 19.20% [2] - The company is focusing on self-innovation and external mergers and acquisitions to drive growth, with a diversified strategic layout aimed at establishing new growth drivers [1] - The company has achieved significant growth in its core products, particularly in the respiratory support segment, which saw an 80.18% increase in revenue in the second half of 2025 [5] Financial Performance Summary - Revenue projections for the company are as follows: 4.2 billion yuan in 2026, 5.285 billion yuan in 2027, and 6.266 billion yuan in 2028, with growth rates of 24%, 26%, and 19% respectively [5] - The net profit attributable to shareholders is expected to reach 462.51 million yuan in 2026, 585.35 million yuan in 2027, and 716.47 million yuan in 2028, with growth rates of 24%, 27%, and 22% respectively [5] - The company's earnings per share (EPS) is projected to be 2.21 yuan in 2026, 2.80 yuan in 2027, and 3.43 yuan in 2028 [5] Business Development - The health monitoring product segment generated 5.87 billion yuan in revenue, growing by 20.08% year-on-year, driven by new product launches [5] - The rehabilitation aids segment reported revenue of 12.44 billion yuan, an increase of 12.68% year-on-year, with significant growth in the hearing business [5] - The company has established strategic partnerships, including one with Royal Philips, to enhance its product offerings in home health monitoring [5] Market Position and Strategy - The company has made significant strides in international markets, with overseas revenue reaching 2.99 billion yuan, a year-on-year increase of 405.05% [5] - The company is pursuing a dual capital platform strategy by applying for a listing on the Hong Kong Stock Exchange, which is expected to support its global expansion [5] - The company is also investing in cutting-edge technologies, including brain-computer interfaces and AI medical applications, to enhance its product portfolio [5]

Investment Rating - The investment rating for the company is "Buy" (maintained) [2][18] Core Insights - The company achieved a revenue of 3.387 billion yuan in 2025, representing a year-on-year growth of 13.56%, and a net profit of 371.61 million yuan, with a year-on-year increase of 19.20% [2] - The company is focusing on self-innovation and external mergers and acquisitions to drive growth, with a strategic layout aimed at creating new growth engines [1] - The company has seen significant growth in its core products, particularly in the respiratory support segment, which experienced an 80.18% year-on-year increase in the second half of 2025 [5] Financial Performance Summary - Revenue projections for 2026-2028 are 4.200 billion, 5.285 billion, and 6.266 billion yuan, with growth rates of 24%, 26%, and 19% respectively [5] - The net profit forecast for the same period is 462.51 million, 585.35 million, and 716.47 million yuan, with growth rates of 24%, 27%, and 22% respectively [5] - The company's P/E ratios for 2026-2028 are projected to be 26.8, 21.1, and 17.3 [5] Business Segment Performance - Health monitoring products generated revenue of 5.87 billion yuan, a year-on-year increase of 20.08%, driven by new product launches [5] - Rehabilitation aids generated 12.44 billion yuan in revenue, up 12.68% year-on-year, with significant growth in the hearing business [5] - The online sales channel achieved revenue of 21.97 billion yuan, a 10.37% increase year-on-year, while offline sales reached 10.55 billion yuan, growing by 23.94% [5] Strategic Initiatives - The company has entered into a strategic partnership with Royal Philips to enhance its product offerings in home health monitoring [5] - The company is pursuing international expansion, with overseas revenue reaching 2.99 billion yuan, a remarkable growth of 405.05% [5] - The company has submitted an application for a dual listing on the Hong Kong Stock Exchange to support its global strategy [5]

Core Insights - The report highlights the significant growth in the multi-metal reserves of the company, with a notable increase in revenue and net profit for the year 2025, indicating a stable upward cycle in performance [5][6][9] - The company has successfully enhanced its gold production cost advantages, maintaining a competitive position in the global market [7][9] Company Performance - In 2025, the company achieved an operating revenue of 171 billion yuan, a year-on-year increase of 25.9%, and a net profit of 29.7 billion yuan, up 36.7% [5] - The basic earnings per share (EPS) for 2025 was reported at 1.1 yuan, reflecting a growth of 36.8% [5] - The company’s multi-metal resource reserves have significantly increased, with gold reserves rising by 9% to 149.48 tons and silver reserves increasing by 282% to 2701.48 tons [6][7] Revenue and Cost Analysis - The revenue from gold sales in 2025 reached 55.05 billion yuan, a 24% increase year-on-year, while silver sales grew by 18% to 11.60 billion yuan [7] - The production costs for gold were reported at 142.18 yuan per gram, showing a decrease of 2.2%, which contributed to an increase in gross margin to 81.63% [7][8] Shareholder Returns - The company has established a diversified investor return system, with a cash dividend of 4.8 yuan per 10 shares, totaling 1.332 billion yuan, resulting in a dividend payout ratio of 44.82% for 2025 [8] - The company has also initiated a share buyback program, with a total repurchase amounting to 34.09 million yuan by the end of 2025 [8] Future Outlook - The company forecasts operating revenues of 209.18 billion yuan, 261.05 billion yuan, and 303.96 billion yuan for the years 2026 to 2028, with net profits expected to reach 50.33 billion yuan, 79.42 billion yuan, and 103.52 billion yuan respectively [9]

Economic Growth and Expectations - The GDP growth target for 2026 is set at 4.5%-5%, reflecting a downward adjustment from previous years[8] - The weighted average GDP growth target for local governments in 2026 is approximately 5.10%, down from 5.37% in 2025[13] - The actual economic growth rate for 2026 is expected to reach around 4.9%, with nominal GDP growth projected to rise to about 4.2%[8] Manufacturing and Investment Trends - Manufacturing investment growth is anticipated to rebound to around 2% in 2026, supported by preemptive investments in key projects[5] - The manufacturing PMI in January 2026 fell to 49.3%, indicating a contraction in manufacturing activity[19] - The investment in the manufacturing sector decreased by 8.6% in 2025, marking the lowest level since 2021[21] Real Estate Market Dynamics - Real estate investment in 2025 declined by 17.2%, with a significant drop in new construction area[26] - The confidence index for real estate developers has reached a historical low, impacting land market transactions negatively[28] - The land transaction area in 2025 decreased by 9.66% year-on-year, with a further decline of 18.33% in January 2026[28] Consumer Confidence and Spending - The consumer confidence index showed a recovery, reaching 89.5 in December 2025, which is expected to positively influence retail sales growth[47] - Retail sales growth for 2025 was 3.7%, with an anticipated increase to around 4% in the first quarter of 2026 due to seasonal factors[47] - The average daily sales during the 2026 Spring Festival increased by 5.7% compared to the previous year[47] Infrastructure and Policy Support - A significant increase in project approvals was noted in January 2026, with 3,041 projects approved, 2.75 times the number from the previous year[39] - Infrastructure investment growth is expected to stabilize and potentially reach 6% in 2026, driven by policy support and project initiation[39] - The focus on "AI + manufacturing" is expected to accelerate investment in manufacturing upgrades in 2026[21]

Core Viewpoint - Zhongke Borui (Beijing) Technology Co., Ltd. has completed a multi-million yuan Series B financing to enhance its brain-computer interface (BCI) technology and clinical applications, aligning with national development strategies for the industry [2][9]. Group 1: Company Overview - Zhongke Borui was established in 2017 and focuses on the transformation and industrialization of BCI technology, emphasizing practical clinical applications rather than conceptual development [4]. - The company collaborates with top medical institutions, such as Capital Medical University Xuanwu Hospital and Tiantan Hospital, to address critical clinical needs in areas like perioperative intensive care and stroke rehabilitation [5]. Group 2: Product Development and Innovation - Zhongke Borui has developed a comprehensive product line that integrates BCI technology with artificial intelligence, covering the entire chain from research and development to clinical application [5][7]. - The company has created innovative products, including the world's only non-invasive multi-channel brain oxygen monitor and a photonic synchronous brain function imaging device, which significantly enhance surgical outcomes in functional neurosurgery [5][7]. Group 3: Strategic Goals and Future Plans - The company aims to establish a full-cycle BCI medical ecosystem that includes diagnosis, monitoring, treatment, and rehabilitation, focusing on brain health [9]. - Following the recent financing, Zhongke Borui plans to increase investment in core technology research, enhance its intellectual property portfolio, and expand production capacity to support market growth [9].

东脑智合成立于2025年11月，注册地位于上海闵行区，已入驻上海脑机接口未来产业集聚区"脑智天地"。据上海市闵行区政府网站 2025年11月27日披露，该公司由东微半导董事长龚轶与中国科学院半导体所研究员裴为华联合创立。 龚轶在半导体领域具备产业化经验，裴为华现任中国脑机接口产业联盟硬件组副主席，从事神经接口技术研究20余年。公司团队配置呈 现 "半导体+神经科学" 的跨学科特征，并引入了生物传感器芯片开发团队。 技术层面，东脑智合的核心产品为液压驱动柔性神经触手电极。据上海证券报2025年12月8日报道，该技术在柔性电极末端集成液压装 置，通过注入生理盐水实现植入形态切换：加压时呈"微针"状刺入脑组织，卸压后恢复柔性随脑组织微动。公司称该技术旨在解决侵入 式电极"微创植入"与"长期稳定"的兼容性问题。 # 企业发展路径 从融资结构看，产业基金独家持股35%，意味着东脑智合在早期阶段即与产业资本形成深度绑定。这种结构的优势在于：芯片定制开发 需要半导体制造资源，而东微半导在功率器件和模拟芯片领域具备技术积累；规模化生产涉及精密加工工艺，华兴源创的检测设备背景 可提供支持。 2026年3月5日， 上海东脑智合技 ...

Group 1 - The report identifies key investment opportunities based on the 2026 National Two Sessions government work report, focusing on themes such as brain-computer interfaces, intelligent driving, humanoid robots, and intelligent agents [3][11][12] - The report emphasizes the importance of selecting themes that are newly introduced, have performance support for the current year, and show expectations for sustained growth [17][18] - The report notes that the market experienced a decline of 2.30% during the week of March 2-6, with only the CSI Dividend Index showing gains, while sectors like pharmaceuticals and technology faced significant losses [22][25] Group 2 - The report highlights the rising stock-bond yield spread, which increased to 0.4%, indicating a decrease in valuation differentiation [27] - Market sentiment has improved, with the sentiment index rising by 18.2% to 45.7, suggesting a recovery in overall market sentiment [28] - The report indicates that the average daily trading volume of the Stock Connect increased by 205.14 billion yuan compared to the previous week, with significant inflows into sectors such as oil and gas, transportation, and non-ferrous metals [40] Group 3 - The report suggests focusing on sectors affected by geopolitical tensions, particularly oil and shipping, due to the ongoing U.S.-Iran conflict [49] - It emphasizes the importance of monitoring government work reports and the "14th Five-Year Plan" for potential investment opportunities [49] - The report discusses the growing significance of computing power supply in the context of AI development, recommending attention to the synergy between computing power and electricity [49]

证券研究报告 ETF 未来产业含量盘点 2026 年 3 月 08 日│中国内地 ETF 点评 ETF 市场观察：政策明确支持未来产业发展，哪些 ETF 持股比例较高？ 近期国家政策密集支持未来产业发展，明确将 6G、具身智能、未来能源、 脑机接口、量子科技等产业列为重点培育方向。基于此，我们采用"核心业 务关联/明确技术布局"的严格标准，对相关概念股进行筛选，并结合最新 指数成分权重，梳理了现有 ETF 在五大方向上的持股结构。结果显示，6G、 具身智能、未来能源分别在跟踪电信/通信、机器人、新能源车电池等类别 指数的 ETF 中含量较高；而量子科技和脑机接口等前沿领域，目前在严格 口径下尚缺乏纯粹主题标的，医疗器械类指数在脑机接口方向的权重占比相 对有限。 ETF 市场回顾：近一周宽基 ETF 净流出，A 股油气 ETF 规模快速增加 近一周（2026.3.2-2026.3.6）宽基 ETF 整体净流出，中证 500、沪深 300、 中证 1000ETF 的净流出额均在 50 亿元以上。行业主题 ETF 中，A 股油气 ETF 总规模在近一周内从 77 亿元增长到 282 亿元，单周规模增幅 265%， ...

Policy Dynamics - The 2026 government work report emphasizes the establishment of a future industry risk-sharing mechanism, aiming to support the development of quantum technology, future energy, embodied intelligence, brain-computer interfaces, and 6G [5][6] - The report indicates a shift towards a collaborative model where state-owned enterprises lead and social capital follows, with national funds directly covering initial R&D losses [5][6] Quantum Technology - Huawei launched the "Galaxy AI Network Flux Integration Solution" at the 2026 World Mobile Communication Conference, significantly reducing the deployment costs and barriers for quantum encryption technology [7][8] - French quantum computing company Pasqal is set to go public via SPAC, with a valuation of $2 billion, showcasing the commercial competitiveness of the neutral atom approach [9][10] - A Chinese research team achieved breakthroughs in solid-state quantum light sources, developing a high-efficiency dual-photon emitter, which aids in the domestic production of optical quantum computers [11] Hydrogen Energy and Nuclear Fusion - The Baowu Clean Energy (Yangjiang) green hydrogen industrial park has officially launched, exploring the direct hydrogen production model from offshore wind power, with a total investment of 11 billion yuan [12][13] - The "14th Five-Year Plan" outlines a trillion-level future industry layout, emphasizing nuclear fusion and green hydrogen alongside major energy projects [14] Brain-Computer Interfaces - Science Corporation has accelerated the commercialization of its PRIMA retinal implant system, raising $230 million in Series C funding to help restore vision for patients with macular degeneration [15][16] Embodied Intelligence - Honor has released its first humanoid robot and "robot phone," which features innovative design and capabilities for physical perception and execution [19] 6G and Commercial Aerospace - The global communication industry is transitioning from 5G-A to 6G, with Huawei and ZTE promoting the large-scale commercial use of the U6GHz frequency band [20][21] - SpaceX plans to launch 1,200 second-generation "Starlink" satellites by the end of 2027, aiming for global seamless coverage, which aligns with the 6G vision of comprehensive connectivity [27][28]